| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8228486 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 7 Pages |
Abstract
Compared with IMRT, IMPT for distal esophageal cancer lowered the dose to the heart, lung, and liver. The AP/LPO/RPO beam arrangement was optimal for sparing all three organs. The dosimetric benefits of protons will need to be tailored to each patient according to their specific cardiac and pulmonary risks. IMPT for esophageal cancer will soon be investigated further in a prospective trial at our institution.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
James M.D., Daniel M.D., Matthew B. M.B.A., C.M.D., Beverly A. C.M.D., Amin V. C.M.D., Ritsuko M.D., Lei Ph.D., X. Ronald Ph.D., Anna M.D., Zhongxing M.D., Wayne L. M.D., Jaffer A. M.D., James D. M.D.,